ARCHIVES

Zaltrap Economics 101: The Pricing And Repricing of an Expensive Drug

This article is from The Cancer Letter archive.

Vol. 38 No. 43 | November 16, 2012

Download PDF Visit The Full Archive

Related Articles

Ultrasound Shown to be Superior Diagnostic Compared to Mammography in Women Ages 30-39

October 26, 2012

Small Business Technology Transfer Program Solicitation

June 23, 1995

In Brief: King Named To Replace Saunders; Zubrod Retires, Will Go To Miami; Perry acting Treatment Chief

June 14, 1974

Tamoxifen Offers Long-Term Benefits For Prevention

March 30, 2007

In Brief: Hayard Of Sloan-Kettering, Leder Of Harvard to Share 1985 Bristol-Myer Award Of $50,000

March 29, 1985

NCAB Committee Ok’s Recompetition of OD Support Contract

May 22, 1992